UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPTN
1926
DELISTED
SpartanNash
SPTN
| $3.22M | ﹤0.01% |
121,664
+44,014
| +57% | +$880K |
|
1927
Dime Commercial Bancshares
DCOM
$1.78B
| $3.22M | ﹤0.01% |
119,546
+38,273
| +47% | +$1M |
|
1928
Monarch Casino & Resort
MCRI
$2.23B
| $3.21M | ﹤0.01% |
37,175
+11,676
| +46% | +$942K |
|
1929
Immunovant
IMVT
$8.25B
| $3.2M | ﹤0.01% |
200,260
+60,169
| +43% | +$910K |
|
1930
Hanmi Financial
HAFC
$946M
| $3.16M | ﹤0.01% |
128,191
+42,483
| +50% | +$971K |
|
1931
Fox Factory Holding Corp
FOXF
$886M
| $3.16M | ﹤0.01% |
121,855
+34,424
| +39% | +$807K |
|
1932
Evolent Health
EVH
$447M
| $3.16M | ﹤0.01% |
280,706
-242,250
| -46% | -$2.22M |
|
1933
InvenTrust Properties
IVT
$2.59B
| $3.16M | ﹤0.01% |
115,216
-471,609
| -80% | -$13.1M |
|
1934
Caleres
CAL
$487M
| $3.15M | ﹤0.01% |
257,451
+152,314
| +145% | +$2.28M |
|
|
CIM
1935
Chimera Investment
CIM
$1B
| $3.15M | ﹤0.01% |
226,804
+50,407
| +29% | +$644K |
|
1936
Standard Motor Products
SMP
$911M
| $3.14M | ﹤0.01% |
102,064
+55,994
| +122% | +$1.55M |
|
1937
VEON
VEON
$3.95B
| $3.13M | ﹤0.01% |
68,008
| – | – |
|
1938
Fastly Inc
FSLY
$3.66B
| $3.13M | ﹤0.01% |
443,665
+112,787
| +34% | +$756K |
|
1939
Ceco Environmental
CECO
$4.14B
| $3.12M | ﹤0.01% |
110,361
+17,224
| +18% | +$429K |
|
1940
Preferred Bank
PFBC
$1.25B
| $3.12M | ﹤0.01% |
36,041
+10,110
| +39% | +$833K |
|
1941
Adaptive Biotechnologies
ADPT
$3.97B
| $3.11M | ﹤0.01% |
266,893
+81,657
| +44% | +$742K |
|
1942
Rush Street Interactive
RSI
$2.88B
| $3.09M | ﹤0.01% |
207,283
+63,532
| +44% | +$788K |
|
1943
Apogee Enterprises
APOG
$908M
| $3.07M | ﹤0.01% |
75,720
+57,339
| +312% | +$2.37M |
|
1944
Clover Health Investments
CLOV
$2.51B
| $3.07M | ﹤0.01% |
1,101,809
+246,545
| +29% | +$811K |
|
1945
Cipher Digital
CIFR
$7.13B
| $3.07M | ﹤0.01% |
642,426
+221,447
| +53% | +$716K |
|
1946
BCE
BCE
$21.2B
| $3.07M | ﹤0.01% |
138,324
-140,421
| -50% | -$3.07M |
|
1947
Energy Recovery
ERII
$443M
| $3.06M | ﹤0.01% |
239,114
+33,076
| +16% | +$448K |
|
1948
TFS Financial
TFSL
$4.93B
| $3.05M | ﹤0.01% |
235,413
+30,623
| +15% | +$394K |
|
|
KRMN
1949
Karman Holdings
KRMN
$7.72B
| $3.04M | ﹤0.01% |
+60,430
| New | +$2.43M |
|
1950
10x Genomics
TXG
$6.61B
| $3.04M | ﹤0.01% |
262,648
-6,841,120
| -96% | -$62.4M |
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.